Danna Markides, M.D.
Department of Emergency Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Emergency Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 1999 | University of Texas Medical Branch, Galveston, Texas, US, M.D |
| 1994 | Austin College, Sherman, Texas, US, Biology, Bachelor of Arts |
Postgraduate Training
| 2025-2025 | Patient Safety Quality Officer Training, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2024-2024 | Quality Improvement Project Lead Training, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2024-2024 | Research Foundations, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 1999-2002 | Emergency Medicine Resident, Emergency Medicine, University of Rochester, Rochester, New York |
Licenses & Certifications
| 2003 | Diplomate of the American Board of Emergency Medicine |
| 2002 | PALS |
| 2002 | ACLS |
| 2002 | Texas Physician License |
| 2002 | ATLS |
Experience & Service
Administrative Appointments/Responsibilities
Patient Safety Quality officer, Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present
Intramural Institutional Committee Activities
Committee Chair, Nocturnal Advisory Committee, The University of Texas MD Anderson Cancer Center, 2026 - Present
Clinical Supervising Officer/Vice Chair, Nocturnal Advisory Committee, The University of Texas MD Anderson Cancer Center, 2024 - 2026
Member, Emergency Medicine Education Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
Honors & Awards
| Hildebrand Academic Scholarship, UTMB |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2026. Malignant Small Bowel Obstruction. Invited. Oncologic Emergency Medicine Conference. Houston, Texas, US.
- 2025. Febrile Neutropenia. Conference. 2025 Oncologic Emergency Medicine Conference: Past, Present, and Future. Houston, Tx, US.
- 2024. Management of Liquid Tumor Issues - Tumor Lysis Syndrome. Conference. Oncologic Emergency medicine Conference. Houston, Texas, US.
International Presentations
- 2025. Antibody Drug Conjugates in Oncology. Invited. University of Nicosia. Nicosia, CY.
- 2025. Spinal Cord Compression in Cancer Patients. Invited. University of Nicosia. Nicosia, CY.
- 2025. Leukemia presentations and febrile neutropenia. Invited. International Medical Conference “The future of medicine”. Chennai, IN.
Formal Peers
- 2026. You're Not Listening. Houston, Texas, US.
- 2024. Car-T 101. Invited. Houston, Texas, US.
- 2024. Adverse Effects of Antibody Drug Conjugates. Invited. Houston, Texas, US.
- 2023. Metastatic Spinal Cord Compression. Invited. Houston, Texas, US.
- 2023. Difficult Conversations in the ED. Invited. Houston, Texas, US.
Selected Publications
Review Articles
- Cruz Carreras MT, Gonzalez Landron F, Lopez N, Padron Alcantara L, Markides DM, Burk KJ, Chaftari P. Hematologic immune-related adverse effects of immune checkpoint inhibitors: a review. Support Care Cancer 33(10), 2025. e-Pub 2025. PMID: 41055801.
- Markides DM, Hita AG, Merlin J, Reyes-Gibby C, Yeung SJ. Antibody-Drug Conjugates: The Toxicities and Adverse Effects That Emergency Physicians Must Know. Ann Emerg Med, 2025. e-Pub 2025. PMID: 39641680.
Abstracts
- Chua W, Dalusung, J, Metwalli, Z, Balan, D, Gaeta, M, Soliman, M, Raphel, S, Samways, J, Stroh, J, Markides, D. Reducing avoidable observation stays in cancer patients requiring procedural interventions through standardized ED pathways. ASCO 44, 2026. e-Pub 2026.
- Markides D, Qdaisat, a, Yeung, SC, Sandoval, M, Dendy, S, Rowland, J, Rodriguez, C, Nguyen, J, Chang, G, Wattana, M. Emergency department utilization in cancer patients receiving bispecific T-cell engagers: a retrospective observational study. Oncologic Emergency Medicine Conference 85.
Book Chapters
- Markides D. Side effects of chemotherapy. In: Oncologic emergency medicine: clinical cases illustrating key concepts. Cambridge University Press, 2026.
- Markides D. TOXICITIES AND ADVERSE EFFECTS OF ANTIBODY DRUG CONJUGATES USED FOR THE TREATMENT OF CANCER. In: Critical Care Toxicology, 3rd edition. Springer Cham.
Patient Reviews
CV information above last modified June 11, 2026